Advertisement
A webcast of Dr. Kurtz's presentation will be available live. You canaccess the webcast at: http://www.torreypinestherapeutics.com. An archivedversion of the remarks will also be available through the Company's web sitefor a limited time following the conference.
Advertisement
About TorreyPines Therapeutics
TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed toproviding patients with better alternatives to existing therapies through theresearch, development and commercialization of small molecule compounds. Thecompany's goal is to develop versatile product candidates each capable oftreating a number of acute and chronic diseases and disorders such asmigraine, chronic pain, muscle spasticity and rigidity, xerostomia andcognitive disorders. The company is currently developing four productcandidates: two ionotropic glutamate receptor antagonists and two muscarinicreceptor agonists. Further information is available athttp://www.torreypinestherapeutics.com.Company Contact: Media Contact: Craig Johnson David Schull TorreyPines Therapeutics, Inc. Russo Partners, LLC 858-623-5665, x158 212-845-4271 [email protected] [email protected] Investor Contact: Rhonda Chiger Rx Communications 917-322-2569 [email protected]
SOURCE TorreyPines Therapeutics, Inc.
